The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Coagulation and cancer: biological and clinical aspects
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012385 · Cited by 1,052
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., & Barbui, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035572 · Cited by 1,012
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., & Degen, J. L. (2005) · Blood · doi:10.1182/blood-2004-06-2272 · Cited by 999
Lyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., Liebman, H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1283 · Cited by 952
Self-citationSanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.23062 · Cited by 781
Prediction of venous thromboembolism in cancer patients
Ay, C., Dunkler, D., Marosi, C., Chiriac, A.-L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., & Pabinger, I. (2010) · Blood · doi:10.1182/blood-2010-02-270116 · Cited by 772
Hutten, B. A., Prins, M. H., Gent, M., Ginsberg, J., Tijssen, J. G. P., & Büller, H. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3078 · Cited by 748
Venous Thromboembolism and Cancer: Risks and Outcomes
Lee, A. Y. Y., & Levine, M. N. (2003) · Circulation · doi:10.1161/01.cir.0000078466.72504.ac · Cited by 721
Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L., & Rafii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.663 · Cited by 713
Hull, R. D., Pineo, G. F., Brant, R. F., Mah, A. F., Burke, N., Dear, R., Wong, T., Cook, R., Solymoss, S., Poon, M.-C., et al. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.022 · Cited by 607
Agnelli, G., Gussoni, G., Bianchini, C., Verso, M., Mandalà, M., Cavanna, L., Barni, S., Labianca, R., Buzzi, F., Scambia, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70232-3 · Cited by 598
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Gomez, M. L., Gomez‐Raposo, C., & Lobo Samper, F. (2008) · Cancer · doi:10.1002/cncr.23524 · Cited by 549
Cancer and venous thromboembolism
Prandoni, P., Falanga, A., & Piccioli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70207-2 · Cited by 540
Self-citationAssessing Risk of Venous Thromboembolism in the Patient With Cancer
Khorana, A. A., & Connolly, G. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3271 · Cited by 539
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Agnelli, G., George, D. J., Kakkar, A. K., Fisher, W., Lassen, M. R., Mismetti, P., Mouret, P., Chaudhari, U., Lawson, F., & Turpie, A. G. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108898 · Cited by 531
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
Mandalà, M., Falanga, A., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr392 · Cited by 512
Self-citationZwicker, J. I., Liebman, H. A., Neuberg, D., Lacroix, R., Bauer, K. A., Furie, B. C., & Furie, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0371 · Cited by 479
Thromboembolism in Hospitalized Neutropenic Cancer Patients
Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., & Lyman, G. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8877 · Cited by 475
Kim, H. K., Song, K. S., Park, Y. S., Kang, Y. H., Lee, Y. J., Lee, K. R., Kim, H. K., Ryu, K. W., Bae, J. M., & Kim, S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00596-8 · Cited by 401
Deitcher, S. R., Kessler, C. M., Merli, G., Rigas, J. R., Lyons, R. M., & Fareed, J. (2006) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029606293692 · Cited by 392
Tissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
de la Serna, J., Montesinos, P., Vellenga, E., Rayón, C., Parody, R., León, A., Esteve, J., Bergua, J. M., Milone, G., Debén, G., et al. (2008) · Blood · doi:10.1182/blood-2007-07-100669 · Cited by 350
Couban, S., Goodyear, M., Burnell, M., Dolan, S., Wasi, P., Barnes, D., MacLeod, D., Burton, E., Andreou, P., & Anderson, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.192 · Cited by 331
How I treat the acquired von Willebrand syndrome
Tiede, A., Rand, J. H., Budde, U., Ganser, A., & Federici, A. B. (2011) · Blood · doi:10.1182/blood-2010-11-297580 · Cited by 327
Palumbo, A., Cavo, M., Bringhen, S., Zamagni, E., Romano, A., Patriarca, F., Rossi, D., Gentilini, F., Crippa, C., Galli, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6844 · Cited by 323
Piccioli, A., Lensing, A. W. A., Prins, M. H., Falanga, A., Scannapieco, G. L., Ieran, M., Cigolini, M., Ambrosio, G. B., Monreal, M., Girolami, A., et al. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00720.x · Cited by 318
Self-citationGemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
Maraveyas, A., Waters, J., Roy, R., Fyfe, D., Propper, D., Lofts, F., Sgouros, J., Gardiner, E., Wedgwood, K., Ettelaie, C., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.017 · Cited by 316
Rak, J. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1267043 · Cited by 301
Larocca, A., Cavallo, F., Bringhen, S., Di Raimondo, F., Falanga, A., Evangelista, A., Cavalli, M., Stanevsky, A., Corradini, P., Pezzatti, S., et al. (2012) · Blood · doi:10.1182/blood-2011-03-344333 · Cited by 288
Self-citationEpidemiology of venous thromboembolism in 9489 patients with malignant glioma
Semrad, T. J., O'Donnell, R., Wun, T., Chew, H., Harvey, D., Zhou, H., & White, R. H. (2007) · Journal of Neurosurgery · doi:10.3171/jns.2007.106.4.601 · Cited by 284
Palumbo, J. S., Potter, J. M., Kaplan, L. S., Talmage, K. E., Jackson, D. G., & Degen, J. L. (2002) · PubMed · Cited by 253
Epidemiology of cancer-related venous thromboembolism
Wun, T., & White, R. H. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.12.001 · Cited by 237
Streiff, M. B., Bockenstedt, P. L., Cataland, S. R., Chesney, C., Eby, C., Fanikos, J., Fogarty, P. F., Gao, S., Garcia-Aguilar, J., Goldhaber, S. Z., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0062 · Cited by 235
CARRIER, M., LE GAL, G., CHO, R., TIERNEY, S., RODGER, M., & LEE, A. Y. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03326.x · Cited by 229
Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
Kuderer, N. M., Ortel, T. L., & Francis, C. W. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4584 · Cited by 216
Procoagulant mechanisms in tumour cells
Falanga, A., Panova-Noeva, M., & Russo, L. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.12.009 · Cited by 201
Self-citationCARRIER, M., LE GAL, G., TAY, J., WU, C., & LEE, A. Y. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04215.x · Cited by 193
Venous Thromboembolism in the Hematologic Malignancies
Falanga, A., & Marchetti, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8197 · Cited by 192
Self-citationKhorana, A. A., Streiff, M. B., Farge, D., Mandala, M., Debourdeau, P., Cajfinger, F., Marty, M., Falanga, A., & Lyman, G. H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3214 · Cited by 162
Self-citationNew horizons in the analysis of circulating cell-derived microparticles
Horstman, L. L., Jy, W., Jimenez, J. J., Bidot, C., & Ahn, Y. S. (2004) · The Keio Journal of Medicine · doi:10.2302/kjm.53.210 · Cited by 150
Cortelezzi, A., Moia, M., Falanga, A., Pogliani, E. M., Agnelli, G., Bonizzoni, E., Gussoni, G., Barbui, T., Mannucci, P. M., & the CATHEM Study Group (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05529.x · Cited by 146
Self-citationIs extensive screening for cancer in idiopathic venous thromboembolism warranted?
van Doormaal, F. F., Terpstra, W. E., van der Griend, R., Prins, M. H., Nijziel, M. R., van de Ree, M. A., Buller, H. R., Dutilh, J. C., ten Cate‐Hoek, A. J., van den Heiligenberg, S. M., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04101.x · Cited by 143
Trappenburg, M. C., van Schilfgaarde, M., Marchetti, M., Spronk, H. M. H., Cate, H. T., Leyte, A., Terpstra, W. E., & Falanga, A. (2009) · Haematologica · doi:10.3324/haematol.13774 · Cited by 142
Self-citationVenous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)
Mandalà, M., Falanga, A., Piccioli, A., Prandoni, P., Pogliani, E. M., Labianca, R., & Barni, S. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.05.001 · Cited by 126
Self-citationRole of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis
Uusitalo‐Järvinen, H., Kurokawa, T., Mueller, B. M., Andrade‐Gordon, P., Friedlander, M., & Ruf, W. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142539 · Cited by 120
Platelet CLEC-2 and podoplanin in cancer metastasis
Lowe, K. L., Navarro‐Núñez, L., & Watson, S. P. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70013-0 · Cited by 119
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells
Falanga, A., Vignoli, A., Marchetti, M., & Barbui, T. (2003) · Leukemia · doi:10.1038/sj.leu.2403004 · Cited by 115
Self-citationMicroparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
Auwerda, J. J. A., Yuana, Y., Osanto, S., de Maat, M. P. M., Sonneveld, P., Bertina, R. M., & Leebeek, F. W. G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-03-0187 · Cited by 113
Cancer Awareness in Atypical Thrombotic Microangiopathies
Obéric, L., Buffet, M., Schwarzinger, M., Veyradier, A., Clabault, K., Malot, S., SCHLEINITZ, N., Valla, D. C., Galicier, L., Bengrine-Lefèvre, L., et al. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0067 · Cited by 97
Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
Falanga, A., Marchetti, M., Vignoli, A., et al. (2003) · PubMed · Cited by 97
Self-citation_, _. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0071 · Cited by 97
Régina, S., Valentin, J.-B., Lachot, S., Lemarié, É., Rollin, J., & Gruel, Y. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.123695 · Cited by 93
Thrombotic Microangiopathy with Targeted Cancer Agents
Blake-Haskins, J. A., Lechleider, R. J., & Kreitman, R. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0804 · Cited by 92
Farge, D., Bosquet, L., Kassab‐Chahmi, D., Mismetti, P., Elalamy, I., Meyer, G., Cajfinger, F., Desmurs‐Clavel, H., Élias, A., Grangé, C., et al. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.12.004 · Cited by 89
Riess, H. B., Pelzer, U., Hilbig, A., Stieler, J., Opitz, B., Scholten, T., Kauschat-Brüning, D., Bramlage, P., Dörken, B., & Oettle, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-361 · Cited by 81
Epidemiology, risk and outcomes of venous thromboembolism in cancer
Russo, L., & Falanga, A. (2011) · Hämostaseologie · doi:10.5482/ha-1170 · Cited by 78
Self-citationStreiff, M. B. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70030-x · Cited by 72
Liu, Y., Wang, Z., Jiang, M., Dai, L., Zhang, W., Wu, D., & Ruan, C. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.11.008 · Cited by 71
Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies
Falanga, A., & Rickles, F. R. (2007) · Hematology · doi:10.1182/asheducation-2007.1.165 · Cited by 67
Self-citationVenous thromboembolism in patients with essential thrombocythemia and polycythemia vera
Reikvam, H., & Tiu, R. V. (2011) · Leukemia · doi:10.1038/leu.2011.314 · Cited by 62
Microparticles in tumor progression
Falanga, A., Tartari, C. J., & Marchetti, M. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70033-6 · Cited by 61
Self-citationGriffiths, G. O., Burns, S., Noble, S., Macbeth, F. R., Cohen, D. R., & Maughan, T. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-355 · Cited by 61
Activation of Clotting Factors in Cancer
Rickles, F. R., & Falanga, A. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-79962-9_3 · Cited by 59
Self-citationAnticancer treatment and thrombosis
Falanga, A., & Marchetti, M. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.10.025 · Cited by 58
Self-citationSiragusa, S., Armani, U., Carpenedo, M., Falanga, A., Fulfaro, F., Imberti, D., Laurora, R., Molinari, A. C., Prisco, D., Silingardi, M., et al. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.09.002 · Cited by 55
Self-citationOvarian Cancer Cells Modulate Human Blood Neutrophils Response to Activation In Vitro
Klink, M., Jastrzembska, K., Nowak, M., Bednarska, K., Szpakowski, M., Szyłło, K., & Sułowska, Z. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02139.x · Cited by 52
Thrombosis in stem cell transplantation
Kansu, E. (2012) · Hematology · doi:10.1179/102453312x13336169156735 · Cited by 50
Lyman, G. H., & Kuderer, N. M. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70029-3 · Cited by 45
Tissue factor and PAR signaling in tumor progression
Ruf, W. (2007) · Thrombosis Research · doi:10.1016/s0049-3848(07)70125-1 · Cited by 44
Genetic pathways linking hemostasis and cancer
Garnier, D., Magnus, N., D’Asti, E., Hashemi, M., Meehan, B., Milsom, C., & Rak, J. W. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70012-9 · Cited by 42
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
Falanga, A., Russo, L., & Tartari, C. J. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.068 · Cited by 38
Self-citationThe protein C pathway in cancer metastasis
Spek, C. A., & Arruda, V. R. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70022-1 · Cited by 24
Low-molecular-weight heparin and survival in lung cancer
Noble, S. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70029-4 · Cited by 23
Rosovsky, R. P. G., & Lee, A. Y. Y. (2010) · Hematology · doi:10.1182/asheducation-2010.1.150 · Cited by 20
New and old anticoagulants in cancer
Verso, M., & Agnelli, G. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70027-0 · Cited by 15
Treatment of thromboembolism in cancer patients
Panova‐Noeva, M., & Falanga, A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.494181 · Cited by 10
Self-citation
Cited by
Disseminated intravascular coagulation
Gando, S., Levi, M., & Toh, C.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.37 · Cited by 572
Combining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508
Cancer-associated pathways and biomarkers of venous thrombosis
Hisada, Y., & Mackman, N. (2017) · Blood · doi:10.1182/blood-2017-03-743211 · Cited by 443
Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., et al. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.03.005 · Cited by 415
How I treat disseminated intravascular coagulation
Levi, M., & Scully, M. (2018) · Blood · doi:10.1182/blood-2017-10-804096 · Cited by 301
Metadata
- Authors
- FALANGA, A., MARCHETTI, M., & VIGNOLI, A.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 11
- Issue
- 2
- Pages
- 223-233
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W2166383168
- Cited by
- 551
- References
- 86
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.